Clinical Trial

cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit

Study acronym: HEP-UHD
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The aim of this study is to conduct a quick assessment of potential liver damage caused by chronic alcohol consumption. Taking advantage of the patient's admission to a specialized detoxification unit, several tests will be performed to determine the extent of liver damage through blood tests, ultrasound, and FibroScan
Trial Details
NCT Number NCT06838468
Lead Sponsor Corporacion Parc Tauli
Conditions Liver Disease Chronic, Cirrhosis, Detoxification, Alcohol Abuse/Dependence
Enrollment 150 participants
Start Date 2024-03-06
Primary Completion 2024-03-12 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-20